Thus, these authors considered the effects of an extract of turmeric and factions of this extract to overcome the functional effects of the two IBD-associated genetic variants—solute carrier protein 22 A4 (SLC22A4, rs1050152) and interleukin-10 (IL10, rs1800896). Here, SLC22A4 is linked to irritable bowel syndrome.